Raymond James & Associates’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$37.9M Buy
383,355
+27,511
+8% +$2.72M 0.02% 543
2024
Q2
$33M Sell
355,844
-62,860
-15% -$5.83M 0.02% 552
2024
Q1
$39.7M Buy
418,704
+103,077
+33% +$9.78M 0.03% 481
2023
Q4
$28.2M Buy
315,627
+25,856
+9% +$2.31M 0.02% 599
2023
Q3
$21.2M Sell
289,771
-15,091
-5% -$1.1M 0.02% 657
2023
Q2
$25.4M Sell
304,862
-18,711
-6% -$1.56M 0.02% 590
2023
Q1
$24.7M Sell
323,573
-20,042
-6% -$1.53M 0.02% 602
2022
Q4
$28.5M Buy
343,615
+53,758
+19% +$4.46M 0.03% 517
2022
Q3
$23M Buy
289,857
+29,748
+11% +$2.36M 0.02% 565
2022
Q2
$19.3M Buy
260,109
+68,837
+36% +$5.11M 0.02% 624
2022
Q1
$17.2M Sell
191,272
-16,805
-8% -$1.51M 0.01% 772
2021
Q4
$23.3M Buy
208,077
+17,085
+9% +$1.91M 0.02% 670
2021
Q3
$24M Sell
190,992
-12,058
-6% -$1.52M 0.02% 608
2021
Q2
$27.5M Sell
203,050
-15,068
-7% -$2.04M 0.03% 554
2021
Q1
$29.6M Buy
218,118
+4,192
+2% +$569K 0.03% 495
2020
Q4
$30.1M Sell
213,926
-33,410
-14% -$4.7M 0.03% 451
2020
Q3
$27.6M Sell
247,336
-12,799
-5% -$1.43M 0.03% 427
2020
Q2
$29.1M Buy
260,135
+31,704
+14% +$3.55M 0.04% 382
2020
Q1
$17.7M Sell
228,431
-18,567
-8% -$1.44M 0.03% 501
2019
Q4
$23.5M Buy
246,998
+5,778
+2% +$550K 0.03% 512
2019
Q3
$18.4M Sell
241,220
-70,613
-23% -$5.38M 0.03% 580
2019
Q2
$27.4M Sell
311,833
-18,735
-6% -$1.64M 0.04% 435
2019
Q1
$29.9M Sell
330,568
-1,583
-0.5% -$143K 0.05% 380
2018
Q4
$23.8M Sell
332,151
-152,969
-32% -$11M 0.04% 416
2018
Q3
$46.5M Buy
485,120
+52,868
+12% +$5.07M 0.07% 242
2018
Q2
$41.1M Sell
432,252
-2,905
-0.7% -$277K 0.07% 256
2018
Q1
$38.2M Sell
435,157
-10,322
-2% -$906K 0.07% 259
2017
Q4
$37.8M Buy
445,479
+93,802
+27% +$7.96M 0.07% 264
2017
Q3
$30.4M Buy
351,677
+48,631
+16% +$4.21M 0.06% 296
2017
Q2
$23.4M Buy
303,046
+35,304
+13% +$2.72M 0.05% 363
2017
Q1
$18.6M Buy
267,742
+2,686
+1% +$186K 0.04% 423
2016
Q4
$15.7M Sell
265,056
-2,931
-1% -$173K 0.04% 452
2016
Q3
$17.8M Buy
267,987
+117,408
+78% +$7.78M 0.05% 383
2016
Q2
$8.14M Buy
150,579
+30,218
+25% +$1.63M 0.03% 637
2016
Q1
$6.22M Buy
120,361
+20,239
+20% +$1.05M 0.02% 719
2015
Q4
$7.03M Sell
100,122
-29,152
-23% -$2.05M 0.03% 653
2015
Q3
$8.05M Sell
129,274
-3,824
-3% -$238K 0.03% 569
2015
Q2
$11.2M Sell
133,098
-6,258
-4% -$526K 0.04% 473
2015
Q1
$10.5M Sell
139,356
-4,707
-3% -$354K 0.05% 432
2014
Q4
$8.95M Buy
144,063
+9,825
+7% +$611K 0.04% 451
2014
Q3
$6.98M Sell
134,238
-501
-0.4% -$26K 0.04% 478
2014
Q2
$6.92M Sell
134,739
-83,991
-38% -$4.31M 0.04% 482
2014
Q1
$10.4M Sell
218,730
-90,696
-29% -$4.31M 0.07% 306
2013
Q4
$13.4M Sell
309,426
-3,807
-1% -$165K 0.1% 222
2013
Q3
$13.5M Sell
313,233
-11,337
-3% -$488K 0.12% 188
2013
Q2
$11.3M Buy
+324,570
New +$11.3M 0.11% 210